AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist
  • 6.410
  • +0.050+0.79%
20min DelayMarket Closed Nov 29 16:00 AET
2.05BMarket Cap-41354P/E (Static)

Clarity Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities
47.94%9.95M
106.17%6.73M
3.26M
Other cash income from operating activities
47.94%9.95M
106.17%6.73M
--3.26M
Cash paid
-54.62%-55.2M
-114.63%-35.7M
-16.63M
Payments to suppliers for goods and services
-54.62%-55.2M
-114.63%-35.7M
---16.63M
Direct interest received
32.62%2.1M
1,989.39%1.58M
--75.62K
Direct tax refund paid
21.52%-80.99K
-485.30%-103.2K
---17.63K
Operating cash flow
-57.23%-43.24M
-106.55%-27.5M
---13.31M
Investing cash flow
Cash flow from continuing investing activities
-1,855.24%-55.31M
111.80%3.15M
-26.71M
Net PPE purchase and sale
-982.44%-504.01K
78.16%-46.56K
---213.15K
Net investment purchase and sale
-1,813.92%-54.8M
112.07%3.2M
---26.5M
Cash from discontinued investing activities
Investing cash flow
-1,855.24%-55.31M
111.80%3.15M
---26.71M
Financing cash flow
Cash flow from continuing financing activities
49,649.97%115.21M
-99.73%231.58K
86.93M
Net common stock issuance
67,428.20%115.19M
-99.80%170.59K
--86.8M
Net other financing activities
-67.21%20K
-53.79%61K
--132K
Cash from discontinued financing activities
Financing cash flow
49,649.97%115.21M
-99.73%231.58K
--86.93M
Net cash flow
Beginning cash position
-43.59%31.21M
555.72%55.34M
--8.44M
Current changes in cash
169.11%16.67M
-151.42%-24.12M
--46.9M
Effect of exchange rate changes
432.85%19.56K
-85.92%-5.88K
---3.16K
End cash Position
53.46%47.9M
-43.59%31.21M
--55.34M
Free cash from
-58.79%-43.74M
-103.64%-27.55M
---13.53M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities 47.94%9.95M106.17%6.73M3.26M
Other cash income from operating activities 47.94%9.95M106.17%6.73M--3.26M
Cash paid -54.62%-55.2M-114.63%-35.7M-16.63M
Payments to suppliers for goods and services -54.62%-55.2M-114.63%-35.7M---16.63M
Direct interest received 32.62%2.1M1,989.39%1.58M--75.62K
Direct tax refund paid 21.52%-80.99K-485.30%-103.2K---17.63K
Operating cash flow -57.23%-43.24M-106.55%-27.5M---13.31M
Investing cash flow
Cash flow from continuing investing activities -1,855.24%-55.31M111.80%3.15M-26.71M
Net PPE purchase and sale -982.44%-504.01K78.16%-46.56K---213.15K
Net investment purchase and sale -1,813.92%-54.8M112.07%3.2M---26.5M
Cash from discontinued investing activities
Investing cash flow -1,855.24%-55.31M111.80%3.15M---26.71M
Financing cash flow
Cash flow from continuing financing activities 49,649.97%115.21M-99.73%231.58K86.93M
Net common stock issuance 67,428.20%115.19M-99.80%170.59K--86.8M
Net other financing activities -67.21%20K-53.79%61K--132K
Cash from discontinued financing activities
Financing cash flow 49,649.97%115.21M-99.73%231.58K--86.93M
Net cash flow
Beginning cash position -43.59%31.21M555.72%55.34M--8.44M
Current changes in cash 169.11%16.67M-151.42%-24.12M--46.9M
Effect of exchange rate changes 432.85%19.56K-85.92%-5.88K---3.16K
End cash Position 53.46%47.9M-43.59%31.21M--55.34M
Free cash from -58.79%-43.74M-103.64%-27.55M---13.53M
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data